EICHORCondition: Recurrent Non-small Cell Lung Cancer · Stage IV Non-small Cell Lung Cancer · Sponsor: Barbara Ann Karmanos Cancer Institute
This research trial studies comprehensive genomic analysis in tissue samples from patients with non-small cell lung cancer that has come back or is stage IV. Comprehensive genomic analysis may identify specific gene mutations (changes in deoxyribonucleic acid \[DNA\]) and help doctors to tailor treatment to target the specific mutations.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| KCI at McLaren Bay Region | Bay City, Michigan, United States | — |
| KCI at Mclaren Bloomfield Hills | Bloomfield Hills, Michigan, United States | — |
| KCI At McLaren Clarkston | Clarkston, Michigan, United States | — |
| Barbara Ann Karmanos Cancer Institute | Detroit, Michigan, United States | — |
| KCI at McLaren Flint | Flint, Michigan, United States | — |
| KCI at McLaren Greater Lansing, Mid Michigan Physicians | Lansing, Michigan, United States | — |
| KCI at McLaren Lapeer Region | Lapeer, Michigan, United States | — |
| KCI at McLaren Macomb | Mount Clemens, Michigan, United States | — |
| KCI at McLaren Central Michigan | Mount Pleasant, Michigan, United States | — |
| KCI at Northern Michigan | Petoskey, Michigan, United States | — |
| KCI at McLaren Port Huron | Port Huron, Michigan, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02178163